Analysis of Pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion

American Journal of Cardiology

Volumn 93, Issue 6, 2004, Pages 780-782

  Tveit, Arnljot ^a   Grundtvig, Morten ^b   Gundersen, Torstein ^b   Vanberg, Paul ^b   Semb, Anne Grete ^b   Holt, Even ^b   Gullestad, Lars ^b  

^a VESTRE VIKEN HOSPITAL TRUST   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; FLECAINIDE; PRAVASTATIN; PROPOFOL; SOTALOL; WARFARIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVERSION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG TOLERANCE; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART RATE; HEART RHYTHM; HUMAN; INFORMED CONSENT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; MEDICAL ASSESSMENT; MEDICAL RECORD; MULTICENTER STUDY; PATIENT SCHEDULING; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REDUCTION; SIDE EFFECT; SINUS RHYTHM; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; DRUG ADMINISTRATION SCHEDULE; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; NORWAY; PRAVASTATIN; RECURRENCE; TREATMENT OUTCOME;

EID: 1542722283     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.12.009     Document Type: Article

References (12)

1. Holm T., Andreassen A.K., Ueland T., Kjekshus J., Froland S.S., Kjekshus E., Simonsen S., Aukrust P., Gullestad L. Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients. Am J Cardiol. 87:2001;815-818.
2. Laufs U., Endres M., Custodis F., Gertz K., Nickenig G., Liao J.K., Bohm M. Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation. 102:2000;3104-3110.
3. Lefer D.J. Statins as potent antiinflammatory drugs. Circulation. 106:2002;2041-2042.
4. Albert M.A., Danielson E., Rifai N., Ridker P.M. Effect of statin therapy on C-reactive protein levels the Pravastatin INflammation/CRP Evaluation (PRINCE): a randomized trial and cohort study. JAMA. 286:2001;64-70.
5. Mitchell L.B., Powell J.L., Gillis A.M., Kehl V., Hallstrom A.P. Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. J Am Coll Cardiol. 42:2003;81-87.
6. Anderson K.P. Lipid-lowering therapy for prevention of ventricular tachyarrhythmias. J Am Coll Cardiol. 42:2003;88-92.
7. Young-Xu Y., Blatt C.M., Bedell S., Graboys T., Bilchik B., Ravid S. Statins reduce the incidence of atrial fibrillation in patients with coronary artery disease. (abstr) J Am Coll Cardiol. 41:2003;301A.
8. Dernellis J., Panaretou M. C-reactive protein and paroxysmal atrial fibrillation evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol. 56:2001;375-380.
9. Chung M.K., Martin D.O., Sprecher D., Wazni O., Kanderian A., Carnes C.A., Bauer J.A., Tchou P.J., Niebauer M.J., Natale A., Van Wagoner D.R. C-reactive protein elevation in patients with atrial arrhythmias inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 104:2001;2886-2891.
10. Takahashi N., Ishibashi Y., Shimada T., Sakane T., Ohata S., Sugamori T., Ohta Y., Inoue S., Nakamura K., Shimizu H., et al. Atrial fibrillation impairs endothelial function of forearm vessels in humans. J Card Fail. 7:2001;45-54.
11. Conway D.S., Pearce L.A., Chin B.S., Hart R.G., Lip G.Y. Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation relationship to stroke risk factors. Circulation. 106:2002;1962-1967.
12. Cai H., Li Z., Goette A., Mera F., Honeycutt C., Feterik K., Wilcox J.N., Dudley S.C. Jr, Harrison D.G., Langberg J.J. Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation potential mechanisms for atrial thrombosis and stroke. Circulation. 106:2002;2854-2858.